grant
A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail
Organization FRIENDS RESEARCH INSTITUTE, INC.Location BALTIMORE, UNITED STATESPosted 15 Sept 2025Deadline 31 May 2030
NIHUS FederalResearch GrantFY202521+ years oldAccess to CareAccidentsActive Follow-upAddressAdministratorAdoptedAdoptionAdultAdult HumanAdverse ExperienceAdverse eventApplication ContextAwardBuprenorphineCaringClinical TrialsCommunitiesCommunity PharmacyConsolidated Framework for Implementation ResearchConsolidated Framework for Implementation ScienceConsolidated Framework for Implementing ChangeContinuity of CareContinuity of Patient CareContinuum of CareControlled StudyCrimeDay CareDoseDropoutDrug PrescribingDrug PrescriptionsDrug usageDrugsEffectivenessEnsureEventFormulationFundingHIPAAHIV riskHealth CareHealth Care ProvidersHealth Insurance Portability and Accountability ActHealth PersonnelHealth Services AccessibilityImprisonmentIndividualInjectableInjectionsInterventionInterviewJailKennedy Kassebaum ActLinkLiteratureMaintenanceMarylandMedicationMental HealthMental Health ServicesMental HygieneMental Hygiene ServicesMethod AcceptabilityNeedlesOpiate agonistOpiate receptor agonistOpiatesOpioidOpioid agonistOpioid receptor agonistOralOverdosePL 104-191PL104-191Partial HospitalizationPatient PreferencesPatient Self-ReportPatientsPharmaceutical PreparationsPharmaciesPharmacistsPharmacy AdministrationPharmacy facilityPhasePlayPoliciesPopulationProceduresProviderPsychological HealthPublic HealthPublic Law 104-191RE-AIMReach, Effectiveness, Adoption, Implementation, and MaintenanceRegulationRelapseReportingResearchResearch DesignRiskRisk BehaviorsRisky BehaviorRoleRuralSafetySecureSelf-ReportService provisionSiteStudy TypeSubcutaneous InjectionsSurvey InstrumentSurveysTechnologyTelemedicineTherapeuticTimeToxicologyTreatment Day CareUnited States Health Insurance Portability and Accountability ActUrineVideoconferencingVisitaccess restrictionsaccess to health careaccess to health servicesaccess to servicesaccess to treatmentaccessibility of health careaccessibility to health careaccessibility to health servicesactive followupadulthoodat risk behavioravailability of servicesbuprenorphine treatmentcare accesscare coordinationcommunity re-entrycommunity reentrycompare effectivenesscontextual factorscoordinating carecost effectivedosagedrug adherencedrug compliancedrug usedrug/agentfollow upfollow-upfollowed upfollowuphealth care accesshealth care availabilityhealth care personnelhealth care service accesshealth care service availabilityhealth care workerhealth providerhealth related quality of lifehealth service accesshealth services availabilityhealth workforceillicit opiateillicit opioidimplementation determinantsimplementation factorsimprovedincarceratedincarcerationinnovateinnovationinnovativemedical personnelmedication adherencemedication compliancemedication for opioid use disordermedication prescriptionmental health careopiate consumptionopiate drug useopiate intakeopiate useopiate use disorderopioid consumptionopioid drug useopioid intakeopioid useopioid use disorderoverdose deathoverdose fatalitiesphysical conditioningphysical healthpreferenceprescribed medicationprimary outcomeprogramsreach, efficacy, adoption, implementation, and maintenancerearrestrecruitreincarcerationrisk minimizationsecondary outcomeservice availabilitysex risk behaviorsexual risk behaviorsocial rolesocial stigmastigmastudy designsubdermal injectionsubstance usesubstance usingtelehealthtooltreatment accesstreatment providervideo conferencing
Description preview
Abstract
This proposed study is a patient preference trial (PPT) of XR-B vs. SL-B in 8 rural jails in Maryland. A total of 500 adults with moderate/severe OUD soon-to-be-released from jail will be recruited and will choose to receive XR-B or SL-B treatment in jail via telemedicine followed by 6-months of post-release XR-B/SL-B treatment via…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click